Anhui Huaheng Biotechnology Co., Ltd.

¥16.90As of Sun 8 Nov 2026, 12:00 UTC
SSE:688639Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (2.91%)
Div yield 0.95%
ROE 2.80%
Biotechnology
Beta (5Y) 0.41
PE TTM 43.62
TSR TTM (52.59%)
Mkt cap ¥4.215B
ROIC 2.67%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥16
(4.25%)
(71.20%)
Buy 3|11|1|1|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.36
0.39
0.40
0.42
10.75%
8.12%
9.27%
19.81%
Revenue¥M
212.5
213.3
212.4
223.4
7.33%
5.79%
8.21%
8.44%
Peers (US$631.8M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.796
1.206
0.936
EBIT/Intx
3.266
0.515
0.539
Own earn%
(40.93)
(113.94)
(82.26)
Sh yield%
27.68
30.33
31.51
Owners
Insiders/Inst%
12.18
40.06
Short interest%
2.83
SBC / revenue%
2.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
12–17
$1 testx
—
Incr. ROIC%
14